These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24485387)

  • 1. Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.
    Kim HK; Andreazza AC; Yeung PY; Isaacs-Trepanier C; Young LT
    J Psychiatry Neurosci; 2014 Jul; 39(4):276-85. PubMed ID: 24485387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder.
    Andreazza AC; Wang JF; Salmasi F; Shao L; Young LT
    J Neurochem; 2013 Nov; 127(4):552-61. PubMed ID: 23692477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.
    Andreazza AC; Shao L; Wang JF; Young LT
    Arch Gen Psychiatry; 2010 Apr; 67(4):360-8. PubMed ID: 20368511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder.
    Hercher C; Chopra V; Beasley CL
    J Psychiatry Neurosci; 2014 Nov; 39(6):376-85. PubMed ID: 24936776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.
    Markota M; Sin J; Pantazopoulos H; Jonilionis R; Berretta S
    Schizophr Bull; 2014 Sep; 40(5):984-91. PubMed ID: 24936023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
    Nikolaus S; Mamlins E; Hautzel H; Müller HW
    Rev Neurosci; 2019 May; 30(4):381-426. PubMed ID: 30269107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.
    Wang JF; Shao L; Sun X; Young LT
    Bipolar Disord; 2009 Aug; 11(5):523-9. PubMed ID: 19624391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder.
    Ho AM; Winham SJ; Armasu SM; Blacker CJ; Millischer V; Lavebratt C; Overholser JC; Jurjus GJ; Dieter L; Mahajan G; Rajkowska G; Vallender EJ; Stockmeier CA; Robertson KD; Frye MA; Choi DS; Veldic M
    J Psychiatr Res; 2019 Oct; 117():45-54. PubMed ID: 31279243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
    Kunii Y; Zhang W; Xu Q; Hyde TM; McFadden W; Shin JH; Deep-Soboslay A; Ye T; Li C; Kleinman JE; Wang KH; Lipska BK
    Am J Psychiatry; 2015 Nov; 172(11):1122-30. PubMed ID: 26206074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
    Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
    Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.
    Xing G; Zhang L; Russell S; Post R
    Schizophr Res; 2006 May; 84(1):36-56. PubMed ID: 16631355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.
    Hoseth EZ; Ueland T; Dieset I; Birnbaum R; Shin JH; Kleinman JE; Hyde TM; Mørch RH; Hope S; Lekva T; Abraityte AJ; Michelsen AE; Melle I; Westlye LT; Ueland T; Djurovic S; Aukrust P; Weinberger DR; Andreassen OA
    Schizophr Bull; 2017 Jul; 43(4):881-890. PubMed ID: 28049760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional coupling of M
    Odagaki Y; Kinoshita M; Meana JJ; Callado LF; García-Sevilla JA
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):869-880. PubMed ID: 31807862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.
    Xing GQ; Russell S; Webster MJ; Post RM
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):143-53. PubMed ID: 14741058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficits in axon-associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia.
    Shao L; Golbaz K; Honer WG; Beasley CL
    Bipolar Disord; 2016 Jun; 18(4):342-51. PubMed ID: 27218831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.
    Owens SJ; Purves-Tyson TD; Webster MJ; Shannon Weickert C
    Psychiatry Res; 2019 Oct; 280():112503. PubMed ID: 31446215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABAA receptor gamma subunits in the prefrontal cortex of patients with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
    Neuroreport; 2004 Aug; 15(11):1809-12. PubMed ID: 15257153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.